vimarsana.com

Allarity Therapeutics Receives Extension from Nasdaq Hearings Panel to Regain Compliance with Listing Rules 5550(a)(2) and 5550(b)(1)

Allarity Therapeutics Receives Extension from Nasdaq Hearings Panel to Regain Compliance with Listing Rules 5550(a)(2) and 5550(b)(1)

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Denmark ,Thomas Jensen ,Thomas Pedersen ,Linkedin ,Nasdaq Hearings Panel On ,Exchange Commission ,Allarity Therapeutics Inc ,Carrotize Pr Communications ,Nasdaq ,Company Contact ,Allarity Therapeutics ,Nasdaq Listing Rules ,Listing Rule ,Nasdaq Hearings Panel ,Bid Price Rule ,Nasdaq Capital Market ,Common Stock ,Drug Response Predictor ,Private Securities Litigation Reform Act ,

vimarsana.com © 2020. All Rights Reserved.